Mohamed S. AbdelBaki, MD, is a pediatric neuro-oncologist at Nationwide Children's Hospital and an assistant professor of Pediatrics at The Ohio State University. Dr. AbdelBaki is responsible for developing phase I trials for brain tumors at Nationwide Children's, and he is the principal investigator for several national clinical trials investigating novel therapies in pediatric neuro-oncology.
Dr. AbdelBaki did his pediatric neuro-oncology fellowship training at one of the largest brain tumor programs in the country: Texas Children's Hospital-Baylor College of Medicine. From 2013 through 2015, Dr. AbdelBaki served as the director of the Pediatric Neuro-Oncology Program at Cardinal Glennon Children's Medical Center, Saint Louis University. In 2015, Dr. AbdelBaki received the Saint Louis University School of Medicine Distinguished Teaching Award, and in 2016, he received the Family Centered Care Award from Nationwide Children's. He is a member of the Central Nervous System Committee in the Children's Oncology Group (COG) as well as the Nationwide Children's Hospital principal investigator for the Pediatric Pacific Neuro-Oncology Consortium (PNOC).
Date of Appointment at Nationwide Children’s Hospital: 08/15/2015
- Pediatric Hematology Oncology
|Fellowship||Texas Children's Hospital - Baylor College of Medi||Date Completed: 06/30/2012|
|Residency||Albany Medical Center Hospital||Date Completed: 06/30/2009|
|Residency||Cairo University Faculty of Medicine||Date Completed: 05/31/2006|
|Internship||Cairo University - Egypt||Date Completed: 02/28/2002|
|Medical School||Cairo University - Egypt||Date Completed: 07/01/2001|